X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Pfizer with WYETH LTD - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

PFIZER vs WYETH LTD - Comparison Results

PFIZER    Change

Pfizer India is a 71% subsidiary of the world's largest pharmaceuticals company Pfizer Inc. Pfizer derives a larger share of its revenues from the pharmaceuticals division (81%). The company also has presence in the animal health (13%) and clinical d... More

WYETH LTD 
   Change

Wyeth Limited is the 51% subsidiary of Wyeth, US and is the sixth largest company among multinationals with revenues of Rs 2.9 bn in FY07. The company derives its revenues from pharmaceutical and OTC segments with focus on various therapeutic areas s... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    PFIZER WYETH LTD PFIZER/
WYETH LTD
 
P/E (TTM) x 28.4 27.7 102.3% View Chart
P/BV x 4.5 5.3 84.3% View Chart
Dividend Yield % 0.7 1.3 56.4%  

Financials

 PFIZER   WYETH LTD
EQUITY SHARE DATA
    PFIZER
Mar-16
WYETH LTD
Mar-13
PFIZER/
WYETH LTD
5-Yr Chart
Click to enlarge
High Rs2,7241,044 260.8%   
Low Rs1,611818 196.9%   
Sales per share (Unadj.) Rs440.9298.6 147.7%  
Earnings per share (Unadj.) Rs48.757.2 85.1%  
Cash flow per share (Unadj.) Rs75.858.4 129.7%  
Dividends per share (Unadj.) Rs15.0017.00 88.2%  
Dividend yield (eoy) %0.71.8 37.9%  
Book value per share (Unadj.) Rs462.9249.5 185.6%  
Shares outstanding (eoy) m45.7522.72 201.4%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x4.93.1 157.6%   
Avg P/E ratio x44.516.3 273.6%  
P/CF ratio (eoy) x28.615.9 179.4%  
Price / Book Value ratio x4.73.7 125.4%  
Dividend payout %30.829.7 103.7%   
Avg Mkt Cap Rs m99,16321,157 468.7%   
No. of employees `0002.90.5 587.2%   
Total wages/salary Rs m2,758400 689.4%   
Avg. sales/employee Rs Th6,981.713,787.4 50.6%   
Avg. wages/employee Rs Th954.5813.0 117.4%   
Avg. net profit/employee Rs Th771.12,643.3 29.2%   
INCOME DATA
Net Sales Rs m20,1706,783 297.3%  
Other income Rs m857353 243.2%   
Total revenues Rs m21,0287,136 294.7%   
Gross profit Rs m4,3101,617 266.5%  
Depreciation Rs m1,23927 4,656.8%   
Interest Rs m56 94.5%   
Profit before tax Rs m3,9231,938 202.5%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m99-5 -1,938.6%   
Tax Rs m1,794632 283.8%   
Profit after tax Rs m2,2281,301 171.3%  
Gross profit margin %21.423.8 89.6%  
Effective tax rate %45.732.6 140.2%   
Net profit margin %11.019.2 57.6%  
BALANCE SHEET DATA
Current assets Rs m16,2996,984 233.4%   
Current liabilities Rs m7,5942,056 369.4%   
Net working cap to sales %43.272.6 59.4%  
Current ratio x2.13.4 63.2%  
Inventory Days Days6599 65.8%  
Debtors Days Days2624 107.6%  
Net fixed assets Rs m8,622244 3,529.2%   
Share capital Rs m458227 201.4%   
"Free" reserves Rs m20,7225,441 380.9%   
Net worth Rs m21,1805,668 373.7%   
Long term debt Rs m2525 100.0%   
Total assets Rs m29,1377,901 368.8%  
Interest coverage x755.5353.3 213.8%   
Debt to equity ratio x00 26.8%  
Sales to assets ratio x0.70.9 80.6%   
Return on assets %7.716.5 46.4%  
Return on equity %10.522.9 45.8%  
Return on capital %19.034.0 55.8%  
Exports to sales %0.10.2 27.3%   
Imports to sales %17.536.3 48.1%   
Exports (fob) Rs m1215 81.1%   
Imports (cif) Rs m3,5262,465 143.0%   
Fx inflow Rs m5215 339.8%   
Fx outflow Rs m1402,677 5.2%   
Net fx Rs m-88-2,662 3.3%   
CASH FLOW
From Operations Rs m3,436923 372.2%  
From Investments Rs m-6,991317 -2,206.0%  
From Financial Activity Rs m-619-481 128.6%  
Net Cashflow Rs m-4,174759 -549.8%  

Share Holding

Indian Promoters % 0.0 0.0 -  
Foreign collaborators % 63.9 51.1 125.0%  
Indian inst/Mut Fund % 7.5 11.3 66.4%  
FIIs % 4.9 7.2 68.1%  
ADR/GDR % 0.0 0.0 -  
Free float % 23.7 30.4 78.0%  
Shareholders   85,207 21,978 387.7%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare PFIZER With:   ALKEM LABORATORIES  FRESENIUS KABI ONCO.  GLENMARK PHARMA  ASTRAZENECA PHARMA  STRIDES SHASUN LTD  

Compare PFIZER With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends Above 35,000 Mark; Bank & IT Stocks Outperform(Closing)

After opening the day flat, share markets in India witnessed positive trading activity throughout the day and ended the day on a strong note.

Related Views on News

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

Sun Pharma: Tough US Scenario Continues to Hit Business (Quarterly Results Update - Detailed)

Nov 20, 2017

The company's India business recovers but the pricing pressure and USFDA issues continue to mar the US revenues.

Dr Reddy's: No Respite from Pricing Pressure in the US (Quarterly Results Update - Detailed)

Nov 13, 2017

Pricing pressure continued to haunt Dr Reddy's although there was a significant improvement in its businesses sequentially.

Cipla: Strong Recovery Post GST (Quarterly Results Update - Detailed)

Nov 10, 2017

Cipla's India business recovers strongly this quarter post the GST issues in the first quarter of this fiscal.

Glenmark: Most Geographies Show Weak Growth (Quarterly Results Update - Detailed)

Nov 7, 2017

Poor show in the US, Latam and India hit profits during the quarter.

More Views on News

Most Popular

Retail Investors or Chickens Waiting to Get Slaughtered in the Stock Market?(Vivek Kaul's Diary)

Jan 9, 2018

The price to earnings ratio of the Nifty 50 is very close to all-time high levels.

Is it Wise to Ignore Bitcoins?(The 5 Minute Wrapup)

Jan 4, 2018

While investing in bitcoins, it would make sense to treat it as another asset class and decide accordingly.

Best ELSS Funds In 2018: Don't Blindly Chase Top Performers(Outside View)

Jan 10, 2018

As the tax-saving season begins, investors hunt for the best ELSS funds for 2018. PersonalFN provides a list of the top ELSS mutual funds of the past year.

Bitcoin Beginners Should Do These Three Things...(Smart Contrarian)

Jan 10, 2018

Three simple points to keep in mind before you consider buying bitcoin.

Resolutions for 2018 - by others(The Honest Truth)

Jan 8, 2018

Ten quirky new year resolutions. Guess by whom?

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

PFIZER SHARE PRICE


Jan 17, 2018 (Close)

TRACK PFIZER

PFIZER - MERCK LTD COMPARISON

COMPARE PFIZER WITH

MARKET STATS